Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Research
    • Structural Heart Disease
    • TAVR
    • Therapies
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home
News You Need to Know Today
Breaking news: Abbott pulls Trifecta heart valves off the market due to early deterioration
Monday, July 31, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Breaking News

Abbott pulls Trifecta heart valves off the market due to early deterioration

The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years. 

READ MORE >
Abbott pulled the Trifecta GTaortic surgical valve off market in July 2023 after it was determined it had early structural valve deterioration (SVD) before 5 years.
Share on Twitter Share on Facebook Share on Linkedin

Abbott pulls Trifecta heart valves off the market due to early deterioration

Share on Twitter Share on Facebook Share on Linkedin
Abbott pulled the Trifecta GTaortic surgical valve off market in July 2023 after it was determined it had early structural valve deterioration (SVD) before 5 years.
The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Catheter kits recalled | Delaying TAVR costs $10K per year | Key PFA trends | Cannabis & CVD
Week in Review: Why healthcare policies don't improve outcomes | Prior authorization reform bill | Staffing shortages
Week in Review: Salaries keep rising | Edwards makes move worth $4.2B | EP trends | Private equity & cardiology
May's Biggest Stories: Reimbursement trends | FDA warns against use of heart devices | What happened to private practices?
Week in Review: Transcatheter mitral valve interventions vs. surgery | All-in-one PFA | Heart disease in mummies
Week in Review: Hospital to pay $24.3M over TAVR allegations | Cardiology salary update | 2 new recalls | HRS 2024
Week in Review: Catheters recalled after death | Value-based reimbursement | AI & cardiology | TMVR valve impresses FDA

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page 1
    • Page 2
    • Page 3
    • Page 4
    • Current page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Sitemap
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • AI in Healthcare
  • Cardiovascular Business
  • HealthExec
  • Health Imaging
  • Radiology Business
 
© 2024 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup